Schmoch, ThomasThomasSchmochGal, ZoltanZoltanGalMock, AndreasAndreasMockMossemann, JanJanMossemannLahrmann, BerndBerndLahrmannGrabe, NielsNielsGrabeSchmezer, PeterPeterSchmezerLasitschka, FelixFelixLasitschkaBeckhove, PhilippPhilippBeckhoveUnterberg, AndreasAndreasUnterbergHerold-Mende, ChristelChristelHerold-Mende2022-05-022022-05-022016-04https://resolver.sub.uni-goettingen.de/purl?gro-2/107543Recently, anti-tumourigenic effects of all-trans-retinoic-acid (ATRA) on glioblastoma stem cells were demonstrated. Therefore we investigated if these beneficial effects could be enhanced by co-medication with epigenetic drugs such as the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) or the DNA-methyltransferase inhibitor 5-aza-2'deoxycytidine (5-AZA).enjournal_article27069124